Mediquest Research Group

Ocala, Florida 34474

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Coronary Restenosis, Graft Occlusion, Vascular, Patients Undergoing Repeat Peripheral Artery Revascularization, Shock, Cardiogenic

Studies at this site

• Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis. — Completed
• A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack — Stopped early
• A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels. — Completed